Investor Profile: Flare Capital Partners — Thesis, Cheque Size & How to Apply

Flare Capital Partners is one of the most specialised healthcare technology venture firms in the world: it does nothing but healthtech, and its LPs include the industry itself. Based in Boston, the firm has invested in 80+ companies and built nearly $1 billion in assets under management. If you are working out how to get funding from Flare Capital, start with its worldview: it is investing in the technology infrastructure transforming the $5.3 trillion US healthcare economy.

Founded in 2013 and led by General Partners Bill Geary, Michael Greeley and Lee Wrubel, Flare closed its first healthcare-tech fund at $200 million in 2015 and announced the close of its third fund with $350 million in commitments in April 2022 — among the industry’s largest dedicated early-stage healthtech funds at the time.

Thesis: what Flare Capital looks for

Flare backs transformational technologies and services enabling value-based care — mobile-first solutions, big-data and analytics platforms, AI and secure infrastructure — anything that improves health outcomes, broadens access and lowers the cost of care. The firm partners with health systems, health plans and industry executives to accelerate adoption: its Industry Advisory Board draws from senior executives whose organisations represent roughly $1.2 trillion in annual revenue and about 15% of US healthcare spending. That distribution muscle is the moat — Flare companies sell into the network.

Sectors and stage

Early stage and emerging growth, exclusively healthcare technology: payer-provider tools, care delivery platforms, health data infrastructure and now AI agents for the medical back office. Flare is a full life-cycle investor, working alongside entrepreneurs across their entire company-building journey. Exact cheque sizes are not publicly disclosed, but the $350M Fund III and early-stage focus point to classic venture cheques across seed through Series B, with reserves for follow-ons.

Notable portfolio and track record

Flare’s portfolio spans the last decade of digital health: Iora Health, Aetion, Somatus, Cohere Health, HealthVerity, Oshi Health, Eden Health, VisitPay, Aspen RxHealth, Bright Health, Welltok and Valence Health, plus newer AI-native bets like knownwell and GenHealth, whose back-office AI agents are built on a Large Medical Model trained on coded claims and clinical histories. The firm also incubated a strategic partnership with Rock Health’s seed fund, doubling down on its deal-flow position in early healthtech.

People and programmes

Beyond the three co-founders — Geary, Greeley (a founding General Partner of Flybridge Capital Partners before Flare) and Wrubel — the firm runs the Flare Scholar programme, a community of 509 rising stars from leading graduate programmes and healthcare institutions that gives participants hands-on venture experience and mentorship. An AI Advisory Council of senior healthcare executives now guides its AI thesis, and a deep bench of Executive Partners — including former CEOs of LabCorp, UnitedHealthcare and other industry giants — works directly with portfolio companies.

How to apply for funding from Flare Capital Partners

Flare does not run a public application portal; founders pitch the team directly via flarecapital.com. Cold outreach works best through healthcare operators in its network — the firm’s stated priority is founders solving healthcare’s hardest challenges with products that its health-system and health-plan partners would actually buy.